Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.69 HKD
Change Today -0.21 / -11.05%
Volume 27.4M
1011 On Other Exchanges
Symbol
Exchange
Hong Kong
Berlin
As of 1:13 AM 07/8/15 All times are local (Market data is delayed by at least 15 minutes).

china nt pharma group co ltd (1011) Snapshot

Open
$1.80
Previous Close
$1.90
Day High
$1.80
Day Low
$1.36
52 Week High
06/1/15 - $3.24
52 Week Low
07/14/14 - $0.84
Market Cap
2.6B
Average Volume 10 Days
10.4M
EPS TTM
$0.0019
Shares Outstanding
1.6B
EX-Date
--
P/E TM
708.9x
Dividend
--
Dividend Yield
--
Current Stock Chart for CHINA NT PHARMA GROUP CO LTD (1011)

Related News

No related news articles were found.

china nt pharma group co ltd (1011) Related Businessweek News

No Related Businessweek News Found

china nt pharma group co ltd (1011) Details

China NT Pharma Group Company Limited, together with its subsidiaries, operates as a third-party promotional and sales services provider of pharmaceuticals and vaccines in the People’s Republic of China. It operates in three segments: Third-Party Pharmaceutical Promotion and Sales; Proprietary Products Production and Sales; and Third-Party Vaccines and Other Pharmaceuticals. The Third-Party Pharmaceutical Promotion and Sales segment engages in selling and marketing third-party manufactured pharmaceutical products to customers, as well as providing marketing and promotion services. The Proprietary Products Production and Sales segment is involved in the production and sale of NT branded products and generic drugs. The Third-Party Vaccines and Other Pharmaceuticals segment provides supply chain services for pharmaceutical/vaccine products. The company also offers logistics and consulting services. China NT Pharma Group Company Limited was founded in 1995 and is headquartered in Shanghai, the People's Republic of China.

497 Employees
Last Reported Date: 04/20/15
Founded in 1995

china nt pharma group co ltd (1011) Top Compensated Officers

Chairman, Chief Executive Officer, Chairman o...
Total Annual Compensation: CNY4.8M
Executive Director
Total Annual Compensation: --
Honorary Advisor
Total Annual Compensation: CNY2.0M
Compensation as of Fiscal Year 2014.

china nt pharma group co ltd (1011) Key Developments

China NT Pharma Group Company Limited, Special/Extraordinary Shareholders Meeting, Jul 02, 2015

China NT Pharma Group Company Limited, Special/Extraordinary Shareholders Meeting, Jul 02, 2015., at 15:00 China Standard Time. Location: Suite 2418, 24/F. Agenda: To approve the placing agreement; to approve the subscription agreement; to authorise any one Director to exercise all the powers of the company and to take all steps as might in their opinion be desirable or necessary in connection with the placing agreement and the subscription agreement to, including without limitation, allot and issue the placing shares and the subscription shares; and to approve all other transactions contemplated under the placing agreement and the subscription agreement.

China NT Pharma Group Company Limited Announces Executive Changes, Effective from May 10, 2015

The board of directors of China NT Pharma Group Company Limited announced that Ms. Mok Ming Wai has tendered her resignation as the company secretary and authorized representative of the Company with effect from 10 May 2015. The Board announced that Mr. Chiu has been appointed as successor to take up the role of Ms. Mok as the company secretary and authorized representative of the Company with effect from 10 May 2015. Mr. Chiu, aged 37, joined the Group in April 2015 as the Group's Chief Financial Officer. He is responsible for the overall financial management and control, accounting, auditing, corporate financing, investor relations and listing rules compliance of the Group. Mr. Chiu has over 13 years of experience in corporate financing, investor relations, auditing, accounting and financial management. Prior to joining the Group, Mr. Chiu was vice president, chief financial officer and company secretary of a company listed on the Main Board of the Stock Exchange.

China NT Pharma Group Company Limited, Annual General Meeting, May 21, 2015

China NT Pharma Group Company Limited, Annual General Meeting, May 21, 2015., at 16:00 China Standard Time. Location: Suite 2418, 24/F,. Agenda: To receive and adopt the audited consolidated financial statements of the company and the reports of the directors and auditors for the year ended 31 December 2014; to consider the re-election of the retiring directors of the company and uthorize the board of directors to fix the remuneration of the directors of the company; to consider the re-appointment of Crowe Horwath (HK) CPA Limited as the auditors of the company and to authorise the board of directors of the company to fix their remuneration; and to consider rights issue.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
1011:HK $1.69 HKD -0.21

1011 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 1011.
View Industry Companies
 

Industry Analysis

1011

Industry Average

Valuation 1011 Industry Range
Price/Earnings 100.0x
Price/Sales 1.9x
Price/Book 7.7x
Price/Cash Flow 946.1x
TEV/Sales 1.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHINA NT PHARMA GROUP CO LTD, please visit www.ntpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.